Northern Trust’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9,197
| Closed | -$61.5K | – | 4464 |
|
|
2025
Q4 | $61.5K | Sell |
9,197
-5,320
| -37% | -$31.6K | ﹤0.01% | 4236 |
|
|
2025
Q3 | $63.7K | Sell |
14,517
-4,370
| -23% | -$20.7K | ﹤0.01% | 4236 |
|
|
2025
Q2 | $83.8K | Sell |
18,887
-22,974
| -55% | -$96K | ﹤0.01% | 4149 |
|
|
2025
Q1 | $237K | Sell |
41,861
-3,041
| -7% | -$38.9K | ﹤0.01% | 3879 |
|
|
2024
Q4 | $947K | Sell |
44,902
-302
| -0.7% | -$6.94K | ﹤0.01% | 3419 |
|
|
2024
Q3 | $1.22M | Buy |
45,204
+342
| +0.8% | +$10.1K | ﹤0.01% | 3273 |
|
|
2024
Q2 | $1.28M | Sell |
44,862
-748
| -2% | -$26.2K | ﹤0.01% | 3139 |
|
|
2024
Q1 | $1.93M | Sell |
45,610
-1,155
| -2% | -$51.9K | ﹤0.01% | 2982 |
|
|
2023
Q4 | $2.5M | Buy |
46,765
+94
| +0.2% | +$4.24K | ﹤0.01% | 2875 |
|
|
2023
Q3 | $2.01M | Buy |
46,671
+531
| +1% | +$24.5K | ﹤0.01% | 2936 |
|
|
2023
Q2 | $2.53M | Buy |
46,140
+26,910
| +140% | +$1.48M | ﹤0.01% | 2874 |
|
|
2023
Q1 | $808K | Buy |
19,230
+138
| +0.7% | +$4.09K | ﹤0.01% | 3288 |
|
|
2022
Q4 | $529K | Sell |
19,092
-63
| -0.3% | -$1.55K | ﹤0.01% | 3485 |
|
|
2022
Q3 | $490K | Sell |
19,155
-42,257
| -69% | -$1.4M | ﹤0.01% | 3516 |
|
|
2022
Q2 | $2.21M | Buy |
61,412
+15,764
| +35% | +$711K | ﹤0.01% | 3000 |
|
|
2022
Q1 | $2.83M | Sell |
45,648
-2,376
| -5% | -$141K | ﹤0.01% | 2917 |
|
|
2021
Q4 | $3.38M | Sell |
48,024
-965
| -2% | -$68.6K | ﹤0.01% | 2940 |
|
|
2021
Q3 | $3.42M | Sell |
48,989
-826
| -2% | -$65.7K | ﹤0.01% | 2981 |
|
|
2021
Q2 | $4.15M | Buy |
49,815
+1,467
| +3% | +$104K | ﹤0.01% | 2964 |
|
|
2021
Q1 | $2.64M | Sell |
48,348
-13,350
| -22% | -$649K | ﹤0.01% | 3104 |
|
|
2020
Q4 | $2.65M | Sell |
61,698
-2,577
| -4% | -$96.2K | ﹤0.01% | 3051 |
|
|
2020
Q3 | $1.94M | Buy |
64,275
+25,996
| +68% | +$874K | ﹤0.01% | 3082 |
|
|
2020
Q2 | $1.19M | Buy |
38,279
+22,400
| +141% | +$603K | ﹤0.01% | 3297 |
|
|
2020
Q1 | $350K | Buy |
15,879
+124
| +0.8% | +$3.36K | ﹤0.01% | 3538 |
|
|
2019
Q4 | $480K | Sell |
15,755
-90
| -0.6% | -$2.59K | ﹤0.01% | 3568 |
|
|
2019
Q3 | $487K | Sell |
15,845
-26,989
| -63% | -$671K | ﹤0.01% | 3544 |
|
|
2019
Q2 | $857K | Sell |
42,834
-1,739
| -4% | -$50.9K | ﹤0.01% | 3404 |
|
|
2019
Q1 | $1.92M | Buy |
44,573
+251
| +0.6% | +$9.1K | ﹤0.01% | 3109 |
|
|
2018
Q4 | $1.41M | Buy |
44,322
+103
| +0.2% | +$4.06K | ﹤0.01% | 3227 |
|
|
2018
Q3 | $2.32M | Buy |
44,219
+5,104
| +13% | +$286K | ﹤0.01% | 3139 |
|
|
2018
Q2 | $2.09M | Buy |
39,115
+30,218
| +340% | +$1.55M | ﹤0.01% | 3185 |
|
|
2018
Q1 | $445K | Sell |
8,897
-165
| -2% | -$7.4K | ﹤0.01% | 3603 |
|
|
2017
Q4 | $299K | Buy |
9,062
+521
| +6% | +$17.6K | ﹤0.01% | 3684 |
|
|
2017
Q3 | $320K | Sell |
8,541
-80
| -0.9% | -$2.37K | ﹤0.01% | 3658 |
|
|
2017
Q2 | $220K | Buy |
8,621
+426
| +5% | +$10.5K | ﹤0.01% | 3767 |
|
|
2017
Q1 | $213K | Buy |
8,195
+321
| +4% | +$9.25K | ﹤0.01% | 3774 |
|
|
2016
Q4 | $240K | Buy |
7,874
+289
| +4% | +$7.35K | ﹤0.01% | 3711 |
|
|
2016
Q3 | $206K | Buy |
7,585
+49
| +0.7% | +$1.36K | ﹤0.01% | 3726 |
|
|
2016
Q2 | $215K | Sell |
7,536
-26,089
| -78% | -$830K | ﹤0.01% | 3702 |
|
|
2016
Q1 | $1.01M | Buy |
33,625
+223
| +0.7% | +$6.32K | ﹤0.01% | 3245 |
|
|
2015
Q4 | $1.16M | Sell |
33,402
-110
| -0.3% | -$3.76K | ﹤0.01% | 3271 |
|
|
2015
Q3 | $1.27M | Buy |
33,512
+24,095
| +256% | +$1.12M | ﹤0.01% | 3244 |
|
|
2015
Q2 | $537K | Buy |
9,417
+2,584
| +38% | +$147K | ﹤0.01% | 3541 |
|
|
2015
Q1 | $398K | Sell |
6,833
-857
| -11% | -$46K | ﹤0.01% | 3674 |
|
|
2014
Q4 | $436K | Sell |
7,690
-10
| -0.1% | -$477 | ﹤0.01% | 3588 |
|
|
2014
Q3 | $315K | Sell |
7,700
-20,934
| -73% | -$963K | ﹤0.01% | 3693 |
|
|
2014
Q2 | $1.3M | Sell |
28,634
-4,814
| -14% | -$202K | ﹤0.01% | 3294 |
|
|
2014
Q1 | $1.59M | Sell |
33,448
-2,284
| -6% | -$104K | ﹤0.01% | 3239 |
|
|
2013
Q4 | $1.68M | Sell |
35,732
-11,590
| -24% | -$506K | ﹤0.01% | 3233 |
|
|
2013
Q3 | $1.89M | Buy |
47,322
+87
| +0.2% | +$3.42K | ﹤0.01% | 3122 |
|
|
2013
Q2 | $1.68M | Buy |
+47,235
| New | +$1.81M | ﹤0.01% | 3077 |
|
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
Northern Trust's HBIO Position: Q1 2026 in Review
Northern Trust sold out of Harvard Bioscience (HBIO) in Q1 2026, closing a stake of 9,197 shares — an estimated $61.5K sold.
Northern Trust first reported a position in HBIO in Q2 2013 and held it in 51 quarters. The position peaked at $4.15M in Q2 2021. 36 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.
- Northern Trust reported no remaining Harvard Bioscience position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 9,197 Harvard Bioscience shares in Q1 2026, an estimated $61.5K.
- Northern Trust first reported a position in Harvard Bioscience in Q2 2013 and held it in 51 quarters.
- Northern Trust's Harvard Bioscience position peaked at $4.15M in Q2 2021.
- 36 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.